Literature DB >> 8114814

Strain polymorphism of Plasmodium falciparum transmission-blocking target antigen Pfs230.

K C Williamson1, D C Kaslow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8114814     DOI： 10.1016/0166-6851(93)90186-2

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN： 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  9 in total

1.  Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax.

Authors:  Masanori Doi; Kazuyuki Tanabe; Shin-Ichiro Tachibana; Meiko Hamai; Mayumi Tachibana; Toshihiro Mita; Masanori Yagi; Fadile Yildiz Zeyrek; Marcelo U Ferreira; Hiroshi Ohmae; Akira Kaneko; Milijaona Randrianarivelojosia; Jetsumon Sattabongkot; Ya-Ming Cao; Toshihiro Horii; Motomi Torii; Takafumi Tsuboi
Journal:  Vaccine       Date:  2011-04-21       Impact factor: 3.641

2.  Structural models for the protein family characterized by gamete surface protein Pfs230 of Plasmodium falciparum.

Authors:  Dietlind L Gerloff; Alison Creasey; Siarhei Maslau; Richard Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-09       Impact factor: 11.205

Review 3.  Transmission-Blocking Vaccines: Old Friends and New Prospects.

Authors:  Festus K Acquah; Joshua Adjah; Kim C Williamson; Linda E Amoah
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

4.  Novel genotyping tools for investigating transmission dynamics of Plasmodium falciparum.

Authors:  Rahel Wampfler; Lincoln Timinao; Hans-Peter Beck; Issiaka Soulama; Alfred B Tiono; Peter Siba; Ivo Mueller; Ingrid Felger
Journal:  J Infect Dis       Date:  2014-04-25       Impact factor: 5.226

Review 5.  The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle.

Authors:  Silvia A Arredondo; Stefan H I Kappe
Journal:  Int J Parasitol       Date:  2016-11-27       Impact factor: 3.981

6.  N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity.

Authors:  Mayumi Tachibana; Yimin Wu; Hideyuki Iriko; Olga Muratova; Nicholas J MacDonald; Jetsumon Sattabongkot; Satoru Takeo; Hitoshi Otsuki; Motomi Torii; Takafumi Tsuboi
Journal:  Clin Vaccine Immunol       Date:  2011-06-29

Review 7.  Flipping the paradigm on malaria transmission-blocking vaccines.

Authors:  Rhoel R Dinglasan; Marcelo Jacobs-Lorena
Journal:  Trends Parasitol       Date:  2008-07-01

8.  Structural and biochemical characterization of Plasmodium falciparum 12 (Pf12) reveals a unique interdomain organization and the potential for an antiparallel arrangement with Pf41.

Authors:  Michelle L Tonkin; Silvia A Arredondo; Bianca C Loveless; Jason J Serpa; Karl A T Makepeace; Natarajan Sundar; Evgeniy V Petrotchenko; Louis H Miller; Michael E Grigg; Martin J Boulanger
Journal:  J Biol Chem       Date:  2013-03-19       Impact factor: 5.157

9.  Profiling the Quality and Quantity of Naturally Induced Antibody Responses Against Pfs230 and Pfs48/45 Among Non-Febrile Children Living in Southern Ghana: A Longitudinal Study.

Authors:  Fermin K Broni; Festus K Acquah; Dorcas Obiri-Yeboah; Evans K Obboh; Esther Sarpong; Linda E Amoah
Journal:  Front Cell Infect Microbiol       Date:  2021-11-25       Impact factor: 5.293
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.